-
Issue 12/2016 - SGL Group completes divestiture of its Energy Efficiency Products business unit
Time of Update: 2022-11-11
We successfully completed the legal divestiture of the Energy Efficiency Products business unit within SGL Group well ahead of schedule.
We successfully completed the legal divestiture of the Energy Efficiency Products business unit within SGL Group well ahead of schedule.
-
Zhongyuan Petrochemical's polypropylene products obtained UL green label certification
Time of Update: 2022-08-24
Recently, Zhongyuan Petrochemical's high melting index transparent polypropylene PPR-MT45 and PPR-MT75 have obtained the US UL green label certification at the same time, indicating that the safety and quality of the two products have reached international standards, indicating that the two products have the ability to export to the United States and North America.
-
In the first half of this year, Vietnam's tuna export revenue increased by 56% year-on-year
Time of Update: 2022-08-16
1 billion VASEP forecasts that tuna exports will continue to grow in the final months of the year, boosting export earnings by 45 percent from 2021 to an estimated $1.
-
China's pharmaceutical and life sciences industry M&A transaction volume hits record high in 2021
Time of Update: 2022-05-25
The report predicts that China's aging population and the impact of the new crown epidemic will continue to increase market demand in the pharmaceutical and life science industries, and the long-term trend will remain positive .
-
The Chinese medicine sector strengthened, and Xinguang Pharmaceutical rose nearly 15
Time of Update: 2022-04-15
As of February 24, a number of proprietary Chinese medicine companies have released their 2021 performance reports, including Pien Tze Huang, Shou Xian Gu, Ji Chuan Pharmaceutical, etc.
-
The concept of vaccines can never escape the "day trip
Time of Update: 2022-01-02
Author: CephalosporinThere have been several daylight scenes since the first exposure of "Omi Keron" in the world. As the most mutated new coronavirus virus so far, it is twice as much as the Delta m
-
JAMA Sub-Journal: Patients with these diseases, beware of cancer
Time of Update: 2021-12-30
(Image source: Drug Discovery World) The Harvard University team recently published a study on JAMA Oncology, which confuses the singularity, but the research data is also surprising enough: 470,000 participants from the UK Biobank The data of the authors show that suffering from any kind of "immune-mediated disease" is related to an 8% increase in the risk of cancer .
-
Announcement of Nanjing Municipal Market Supervision Bureau on 7 batches of unqualified foods (No. 36 in 2021
Time of Update: 2021-09-18
Recently, the Nanjing Municipal Market Supervision Administration has completed 518 batches of food safety supervision and sampling tasks at the city level , involving processed food products, edi
-
With the rapid development of my country's vaccine industry, the pharmaceutical machinery industry will usher in opportunities and challenges
Time of Update: 2021-08-27
Forecasts show that according to the development trend of the domestic vaccine industry, China's vaccine market will continue to maintain rapid growth in the future, and it will exceed 60 billion yuan in 2021 .
reactor Generally speaking, as China's vaccine industry enters a stage of rapid development, pharmaceutical equipment will also usher in more opportunities .
-
Increased psychological stress inhibits immune cell movement
Time of Update: 2021-05-22
Research conducted experiments using mice and found that under stress, their nervous system would send out signals to inhibit the movement of immune cells, making them unable to cope with the invasion of diseases.
-
Takeda's quadrivalent vaccine TAK-003 enters the EU review and will apply for listing in many places around the world
Time of Update: 2021-04-24
Takeda Pharmaceuticals (Takeda) recently announced that the European Medicines Agency (EMA) has accepted the application documents for its dengue vaccine TAK-003, which is being developed for people aged 4-60 to prevent dengue fever caused by any dengue virus serotype (Dengue).
-
Johnson & Johnson invests US$780 million in new flu treatment drugs
Time of Update: 2021-04-19
The company is willing to bet up to $780 million on a new drug, Cidara Therapeutics claims, this drug can eliminate all flu strains.
-
Come on Monday to the CCR spirit one morning
Time of Update: 2021-04-18
The author mainly applied variable selection algorithm to screen prognostic-related genes, and through leave-one-out cross-validation, trained a random forest classifier based on the first 21 genes (BRAVO-DX).
-
Epichlorohydrin Daily: Stable operation
Time of Update: 2021-04-06
On the trading day (September 25, 2012), the epichlorohydrin raw material market slowed down, and the high level was adjusted: (omitted, see the full version for details).
On the trading day (September 25, 2012), the quotations of epichlorohydrin manufacturers rose sharply, pulling the market: (omitted, see the full version for details).
-
GlaxoSmithKline and Sanofi have teamed up to develop the covid-19 vaccine
Time of Update: 2021-02-28
"The development of a vaccine candidate for covid-19 based on adrenal recombination has the potential to reduce vaccine doses and provide more people with vaccines to end the pandemic, help the world prepare better, and even prevent future coronavirus outbreaks," Bright commented.
